Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TB 402

Known as: TB-402, TB402 monoclonal antibody 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
TB-402 is a long-acting monoclonal antibody that partially inhibits factor VIII. A single administration of TB-402 was effective… Expand
Is this relevant?
2012
2012
BACKGROUND TB-402 is a partially inhibiting antibody of factor VIII that is under development as a long-acting anticoagulant… Expand
Is this relevant?
2012
2012
INTRODUCTION Partial inhibition of Factor VIII (FVIII) may provide antithrombotic efficacy whilst avoiding excessive… Expand
Is this relevant?
2011
2011
BACKGROUND TB-402 is a novel anticoagulant monoclonal antibody with a prolonged antithrombotic effect resulting from its partial… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
Review
2011
Review
2011
The therapeutic armamentarium of parenteral anticoagulants available to clinicians is mainly composed by unfractionated heparin… Expand
  • figure 1
  • table 2
  • table 3
Is this relevant?
2010
2010
BACKGROUND TB-402, a human monoclonal antibody that partially inhibits Factor VIII activity (FVIII:C), is being developed as a… Expand
Is this relevant?
2010
2010
Total VTE was lower in each of the TB-402 groups compared to the enoxaparin group: 16.7% (9.8-26.9), 23.9% (15.3-35.3), 24.1%(16… Expand
Is this relevant?